Fundraising Fox
Elphogene
Prague, CZ · 1 known investors
Find your way into Elphogene
Sign up to see every warm intro you have to Elphogene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Elphogene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients. The company is a biotechnology spin-off from the Genomac Research Institute.
Founders & leadership
MM
Marek MinárikCo-founder
Investors · 1
Frequently asked questions
- What does Elphogene do?
- Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients. The company is a biotechnology spin-off from the Genomac Research Institute.
- Who founded Elphogene?
- Elphogene was founded by Marek Minárik.
- Who are Elphogene's investors?
- Elphogene's investors include Biotech Investments S.R.O.
- Where is Elphogene headquartered?
- Elphogene is headquartered in Prague, CZ.